Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) Return on Assets (2016 - 2025)

Historic Return on Assets for Utah Medical Products (UTMD) over the last 15 years, with Q3 2025 value amounting to 0.1%.

  • Utah Medical Products' Return on Assets fell 200.0% to 0.1% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.1%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.1% for FY2024, which is 200.0% down from last year.
  • According to the latest figures from Q3 2025, Utah Medical Products' Return on Assets is 0.1%, which was down 200.0% from 0.1% recorded in Q2 2025.
  • In the past 5 years, Utah Medical Products' Return on Assets registered a high of 0.14% during Q3 2022, and its lowest value of 0.09% during Q1 2021.
  • Moreover, its 5-year median value for Return on Assets was 0.12% (2024), whereas its average is 0.12%.
  • As far as peak fluctuations go, Utah Medical Products' Return on Assets tumbled by -400bps in 2021, and later soared by 400bps in 2022.
  • Quarter analysis of 5 years shows Utah Medical Products' Return on Assets stood at 0.13% in 2021, then rose by 5bps to 0.13% in 2022, then fell by -6bps to 0.12% in 2023, then fell by -12bps to 0.11% in 2024, then fell by -13bps to 0.1% in 2025.
  • Its Return on Assets stands at 0.1% for Q3 2025, versus 0.1% for Q2 2025 and 0.11% for Q1 2025.